HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute lung injury by endotoxin-induced mediators: prevention by HWA 138, a new xanthine derivative.

Abstract
We attempted to mimic septic conditions in vitro by using a model of isolated perfused rabbit lung (IPRL) and evaluated the effects of endotoxin or endotoxin-induced mediators (or both) on it. Moreover, we determined the salutary effects of HWA 138, a new xanthine derivative, against endotoxin-related lung injury. To study this, heparinized human blood was centrifuged, following which the plasma complement was inactivated by heat treatment and the isolated and washed buffy coat cells were then added to it. This was followed by incubation of aliquot suspension with and without endotoxin (lipopolysaccharide [LPS], 100 ng/ml) at 37 degrees C for 2 hours. Plasma was then harvested and is referred to as sepsis-like plasma (SLP). Control plasma (CP) was not exposed to LPS. IPRLs were then perfused with SLP, CP, LPS itself, or both LPS and CP without additional white blood cells. Endotoxin itself did not induce any changes in the presence or in the absence of control plasma; however, sepsis-like plasma led to the development of lung edema, as evidenced by significantly elevated lung water and pulmonary artery pressure. Administration of HWA 138 before the addition of SLP prevented the SLP-induced lung injury. These results lead us to conclude that lung injury is caused by LPS-induced mediators rather than being directly caused by LPS. The results also suggest that HWA 138 may be a useful agent in the treatment of sepsis-induced pulmonary injury.
AuthorsS Bahrami, Y H Yu, H Redl, G Schlag
JournalThe Journal of laboratory and clinical medicine (J Lab Clin Med) Vol. 125 Issue 4 Pg. 487-92 (Apr 1995) ISSN: 0022-2143 [Print] United States
PMID7706904 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lipopolysaccharides
  • 1-(5-hydroxy-5-methylhexyl)-3-methylxanthine
  • Cyclic AMP
  • Pentoxifylline
Topics
  • Animals
  • Cyclic AMP (biosynthesis)
  • Female
  • Humans
  • Lipopolysaccharides (toxicity)
  • Lung (drug effects)
  • Male
  • Neutrophils (physiology)
  • Pentoxifylline (analogs & derivatives, pharmacology)
  • Rabbits
  • Sepsis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: